Tan Benjamin Y Q, Ngiam Nicholas J H, Sunny Sibi, Kong Wan Yee, Tam Howen, Sim Tiong Beng, Leong Benjamin S H, Bhartendu Chandra, Paliwal Prakash R, Seet Raymond C S, Chan Bernard P L, Teoh Hock Luen, Sharma Vijay K, Yeo Leonard L L
Division of Neurology, Department of Medicine, National University Health System, Singapore, Singapore.
Department of Emergency Medicine, National University Health System, Singapore, Singapore.
J Stroke Cerebrovasc Dis. 2018 Jun;27(6):1539-1545. doi: 10.1016/j.jstrokecerebrovasdis.2018.01.005. Epub 2018 Feb 13.
In acute ischemic stroke (AIS), treatment with intravenous tissue-type plasminogen activator (IV-tPA) is time-sensitive. All stroke centers make continual efforts to reduce door-to-needle time (DNT) with varying success. We present the impact of modifications to our stroke activation protocol on DNT.
We included 404 consecutive patients with AIS receiving IV-tPA between January 2014 and December 2016. First changes in stroke activation protocol were made in March 2015 in the form of prenotification by paramedics, direct transfer from ambulance to computed tomography (CT) scanner, and rapid en route neurological assessment by an emergency physician and neurologist. In March 2016, a second amendment was made where a stroke nurse accompanied the patient to expedite various steps in the treatment pathway, including endovascular treatment in eligible cases.
Both protocol amendments resulted in improvement in DNT and door-to-CT time from 84 ± 47 minutes before intervention to 69 ± 33 minutes after protocol amendment 1 to 59 ± 37 minutes after protocol amendment 2. In particular, the second amendment (144 patients) showed significant shortening of DNT compared with the 137 patients before (59 ± 37 minutes versus 69 ± 33 minutes, P = .020), with a higher percentage achieving the target of 60 minutes (68.1% versus 48.2%, P < .001). This finding was attributed to a reduction in both door-to-CT time and CT-to-needle time. This improvement remained consistent over subsequent months.
The application of a simple systems-based, multidisciplinary stroke activation protocol may help in significant reduction in DNT. Encouraging increased patient ownership by stroke nurses appeared to be a promising approach for timely administration of definitive acute therapies.
在急性缺血性卒中(AIS)中,静脉注射组织型纤溶酶原激活剂(IV-tPA)治疗具有时间敏感性。所有卒中中心都在不断努力缩短从入院到静脉溶栓治疗开始的时间(DNT),但成效各异。我们展示了对卒中激活方案的修改对DNT的影响。
我们纳入了2014年1月至2016年12月期间连续接受IV-tPA治疗的404例AIS患者。2015年3月首次对卒中激活方案进行了修改,形式包括护理人员预先通知、患者从救护车直接转运至计算机断层扫描(CT)扫描仪,以及由急诊医生和神经科医生在途中进行快速神经学评估。2016年3月进行了第二次修改,即由一名卒中护士陪同患者,以加快治疗路径中的各个步骤,包括在符合条件的病例中进行血管内治疗。
两次方案修改均使DNT和从入院到CT检查的时间得到改善,从干预前的84±47分钟缩短至方案修改1后的69±33分钟,再到方案修改2后的59±37分钟。特别是,第二次修改(144例患者)与之前的137例患者相比,DNT显著缩短(59±37分钟对69±33分钟,P = 0.020),达到60分钟目标的患者比例更高(68.1%对48.2%,P < 0.001)。这一发现归因于从入院到CT检查的时间和从CT检查到静脉溶栓治疗开始的时间均缩短。这种改善在随后几个月中保持一致。
应用基于系统的简单多学科卒中激活方案可能有助于显著缩短DNT。鼓励卒中护士增强对患者的管理似乎是及时给予确定性急性治疗的一种有前景的方法。